IP Library Granted Patent US 10,583,236
Granted Patent B2
US 10,583,236 · App. 15/398,069 · Granted Mar 10, 2020

Recirculating dialysate fluid circuit for blood measurement

Inventors: Bryant J. Pudil (Plymouth, MN); Thomas E. Meyer (Stillwater, MN); David B. Lura (Maple Grove, MN); Martin T. Gerber (Maple Grove, MN)
Assignee: Medtronic, Inc.
A61M1/1696A61M1/14A61M1/165A61M1/1605A61M1/1613A61M1/1619A61M1/1694A61M1/28A61M1/3406A61M1/3472B01D15/08B01D15/362A61M2202/0498A61M2205/15A61M2205/3317A61M2205/3324A61M2205/3334
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,583,236
App. No.
15/398,069
Granted
Mar 10, 2020
Kind
B2
Abstract

A blood based solute monitoring system for measuring at least one blood solute species that has a first recirculation flow path in fluid communication with a dialyzer. The first recirculation flow path is configured to allow a fluid to recirculate through a dialyzer such that the concentration of at least one solute species in the fluid becomes equilibrated to the solute species concentration of the blood in a blood compartment of the dialyzer. The blood solute monitoring system has at least one sensor to measure a fluid characteristic.

Claims (15)

1. A method for determining an effective clearance of a dialyzer, comprising:

measuring a first conductivity value of a dialysate flowing from an outlet of the dialyzer not having contacted a urease containing material layer of a sorbent regeneration system;

measuring a second conductivity value of the dialysate flowing from the outlet of the dialyzer after the dialysate has contacted the urease containing material layer of the sorbent regeneration system;

intermittently providing an electrolyte bolus or diluent to a dialysate flow path and measuring a bolus conductivity of the dialysate passing to the dialyzer to provide a third conductivity value;

measuring a bolus conductivity of the dialysate passing from the dialyzer to provide a fourth conductivity value;

measuring a dialysate flow rate; and

determining the effective clearance of the dialyzer from the third and fourth conductivity values.

2. The method of claim 1 , further comprising:

determining a BUN (blood urea nitrogen) and/or a blood concentration of a solute from the effective clearance of the dialyzer from the first and second conductivity values.

3. The method of claim 1 , further comprising the step of determining a urea content of the dialysate flowing from the dialyzer based at least in part on a difference in conductivity between the first and second conductivity values.

4. The method of claim 1 , wherein the dialysate contacts a plurality of materials of the sorbent regeneration system in a sequential order; wherein the plurality of materials are contained in one or more sorbent cartridges, and wherein at least one material includes an ion exchange resin selective for calcium ions and magnesium ions and releasing hydrogen ions in exchange.

5. The method of claim 1 , further comprising:

determining a third conductivity value of the equilibrated dialysate that has contacted an additional material layer other than the material layer(s) contacted by the dialysate of the first or second conductivity value; and

determining a blood solute concentration of at least a second blood solute from either the second and third conductivity values or the first and third conductivity values.

6. The method of claim 1 , further comprising calculating one or more of the selected measures: URR (urea reduction ratio), Kt/V, eKt/V (equilibrated Kt/V), and PCR (protein catabolic rate), wherein K stands for dialyzer clearance rate, t stands for dialysis time, and V stands for volume of distribution of urea; and wherein Kt/V, eKt/V and PCR are each determined based on a difference between the first and second conductivity values; and wherein URR is determined by calculating a first BUN (blood urea nitrogen) prior to dialysis and a second BUN (blood urea nitrogen) post dialysis.

Assignments (3)
SECURITY INTEREST Recorded Dec 1, 2025
From: MOZARC MEDICAL US LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES V, LP
Reel/Frame 073800/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2023
From: MEDTRONIC, INC.
To: MOZARC MEDICAL US LLC
Reel/Frame 063375/0659 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2017
From: PUDIL, BRYANT J.; MEYER, THOMAS E.; LURA, DAVID B.; GERBER, MARTIN T.
To: MEDTRONIC, INC.
Reel/Frame 040840/0453 →
Continuity (4)
Division 13836538 · Mar 15, 2013
Provisional Application 61760033 · Feb 1, 2013
Provisional Application 61750760 · Jan 9, 2013
Related Publication 20170112991A1 · Apr 27, 2017